Immune therapy after surgery lowers relapse risk in patients with high-risk melanoma
Patients with high-risk melanoma who had a course of pembrolizumab after their surgery had a longer time before their disease recurred than patients who got either ipilimumab or high-dose interferon after surgery. These findings ...
Jun 3, 2021
0
1